Quality of life of African-American and white long term breast carcinoma survivors.

Abstract:

BACKGROUND:Increasingly, the quality of life (QOL) of women diagnosed with breast carcinoma is being studied. However, there is little information regarding long term survivors among ethnic minority women. The purpose of this study was to describe the QOL of long term breast carcinoma survivors (BCS) and to examine the role of ethnicity in influencing their well-being. METHODS:The authors conducted a mailed survey to examine QOL, health perceptions, and life stress among long term BCS. Subjects diagnosed between 1989 and 1990 were identified among respondents to a prior study who were originally recruited from the California Tumor Registry. This survey instrument included standard measures of QOL (e.g., the RAND SF-36 Health Perceptions Scale, the Cancer Rehabilitation and Evaluation Survey-Short Form [CARES-SF], and the Ladder of Life) and new items. RESULTS:Two hundred and seventy-eight women participated; 117 were African-American, and 161 were white. The initial univariate evaluation of the CARES-SF and the RAND SF-36 Health Perceptions Scale suggested potential ethnicity-related differences in QOL. To control for various medical and demographic characteristics and to examine the potential relation between ethnicity and QOL, multiple regression analyses were conducted. The final model accounted for 45% (R-square = 0.450) of the variance in QOL with general health perception, life stress, income, partnership status, and comorbid conditions included in the model. CONCLUSIONS:The results of this study suggest that, overall, BCS report favorable health-related QOL. Differences in QOL outcomes are attributable to socioeconomic and life-burden factors and not to ethnicity.

journal_name

Cancer

journal_title

Cancer

authors

Ashing-Giwa K,Ganz PA,Petersen L

doi

10.1002/(sici)1097-0142(19990115)85:2<418::aid-cnc

subject

Has Abstract

pub_date

1999-01-15 00:00:00

pages

418-26

issue

2

eissn

0008-543X

issn

1097-0142

pii

10.1002/(SICI)1097-0142(19990115)85:2<418::AID-CNC

journal_volume

85

pub_type

杂志文章

相关文献

CANCER文献大全
  • Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S.

    abstract:BACKGROUND:Heavy alcohol consumption, viral hepatitis, and diabetes are risk factors for hepatocellular carcinoma (HCC). However, to the authors' knowledge, the information concerning their interaction effect in patients with risk of HCC is sparse. METHODS:A population-based, case-control study of HCC was conducted du...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.20427

    authors: Yuan JM,Govindarajan S,Arakawa K,Yu MC

    更新日期:2004-09-01 00:00:00

  • Challenges in the recruitment of adolescents and young adults to cancer clinical trials.

    abstract::The adolescent and young adult (AYA) oncology population has seen inferior progress in cancer survival compared with younger children and older adults over the past 25 years. Previously, AYAs had the best survival rates due to the prevalence of highly curable diseases including Hodgkin lymphoma and germ cell tumors, y...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.23060

    authors: Burke ME,Albritton K,Marina N

    更新日期:2007-12-01 00:00:00

  • Patterns of recurrence following curative resection of adenocarcinoma of the colon and rectum.

    abstract::This study explores the patterns of recurrence after "curative" operation for colorectal cancer. For an 11-year period, 1960-1971, 281 evaluable patients were resected at the Peter Bent Brigham Hospital. Crude five-year survival in these patients was 49%, but only 10% of those with recurrence lived five years. A total...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19800615)45:12<2969::aid-cncr282

    authors: Olson RM,Perencevich NP,Malcolm AW,Chaffey JT,Wilson RE

    更新日期:1980-06-15 00:00:00

  • Treatment of recurrent epithelial ovarian cancer.

    abstract::The majority of patients with advanced ovarian cancer progress after first-line therapy and require further treatment. Tumor biology, prior chemotherapy, responses to previous therapy, performance status, and toxicity are the characteristics that influence treatment choice. These criteria have been linked to the time ...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.32500

    authors: Pignata S,Pisano C,Di Napoli M,Cecere SC,Tambaro R,Attademo L

    更新日期:2019-12-15 00:00:00

  • Disseminated coagulopathy in chronic myelomonocytic leukemia.

    abstract::The clinical and laboratory features of nine patients with chronic myelomonocytic leukemia are described. Hepatic or splenic enlargement accompanied by an absolute monocytosis in an older patient with an elevated serum or urine lysozyme and serum vitamin B12 levels were characteristic of the majority of patients in th...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197912)44:6<2249::aid-cncr282044

    authors: Gingrich RD,Burns CP

    更新日期:1979-12-01 00:00:00

  • Small cell carcinomas of the parotid gland. A clinicopathologic study of three cases.

    abstract::Clinical, histological and ultrastructural features of three small cell carcinomas arising in the parotid gland are presented. The light microscopic appearance of two of the neoplasms suggested neuroendocrine cell derivation, confirmed by electron microscopy in both instances. The fine structure of the third neoplasm ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19831201)52:11<2115::aid-cncr282

    authors: Kraemer BB,Mackay B,Batsakis JG

    更新日期:1983-12-01 00:00:00

  • Treatment of patients with advanced nonsmall cell lung carcinoma using docetaxel and gemcitabine plus granulocyte-colony stimulating factor.

    abstract:BACKGROUND:A combination regimen comprised of docetaxel, gemcitabine, and granulocyte-colony stimulating factor (G-CSF) was studied in patients with advanced nonsmall cell lung carcinoma (NSCLC) to determine its antitumor efficacy and tolerance. METHODS:Thirty-four patients with advanced measurable NSCLC (3 patients w...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:

    authors: Hejna M,Kornek GV,Raderer M,Ulrich-Pur H,Fiebiger WC,Marosi L,Schneeweiss B,Greul R,Scheithauer W

    更新日期:2000-08-01 00:00:00

  • Women age < or = 35 years with primary breast carcinoma: disease features at presentation.

    abstract:BACKGROUND:The purpose of the current study was to describe a population of young patients with breast carcinoma, their characteristics at the time of diagnosis, and the association of these characteristics with disease recurrence and survival. METHODS:Four hundred fifty-two women age < or = 35 years with breast carci...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.21070

    authors: Gonzalez-Angulo AM,Broglio K,Kau SW,Eralp Y,Erlichman J,Valero V,Theriault R,Booser D,Buzdar AU,Hortobagyi GN,Arun B

    更新日期:2005-06-15 00:00:00

  • Absence of c-KIT and members of the epidermal growth factor receptor family in refractory germ cell cancer.

    abstract:BACKGROUND:Germ cell tumors (GCTs) in adolescent and young males are very sensitive to cisplatin-based chemotherapy. However, 10-20% of the patients cannot be cured by currently available therapeutic options. Once a tumor does not respond to cisplatin, current therapeutic modalities offer only a chance for short pallia...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.10671

    authors: Kollmannsberger C,Mayer F,Pressler H,Koch S,Kanz L,Oosterhuis JW,Looijenga LH,Bokemeyer C

    更新日期:2002-07-15 00:00:00

  • Thyroid medullary carcinoma with thyroglobulin immunoreactivity in sporadic multiple endocrine neoplasia type 2-B.

    abstract:BACKGROUND:Thyroid carcinomas historically have been divided into two groups according to their presumedly separate embryonic origins: those of neuroectodermal derivation (parafollicular or medullary carcinoma [MCT]) and those of foregut endodermal origin (follicular and papillary carcinomas). The validity of this conc...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19940801)74:3<928::aid-cncr28207

    authors: Kovacs CS,Masé RM,Kovacs K,Nguyen GK,Chik CL

    更新日期:1994-08-01 00:00:00

  • Chemotherapy of advanced breast cancer: a randomized trial of vincristine, Adriamycin, and cyclophosphamide (VAC) versus cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP).

    abstract::Fifty-one patients with metastatic breast cancer were randomly allocated to receive either a four drug combination consisting of cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP), or a combination of vincristine, Adriamycin, and cyclophosphamide (VAC) with cross-over on relapse. Objective responses...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/1097-0142(19811001)48:7<1517::aid-cncr2820

    authors: Carmo-Pereira J,Costa FO,Henriques E

    更新日期:1981-10-01 00:00:00

  • Immunoelectron microscopic localization of prostatic-specific antigen in human prostate by the protein A-gold complex.

    abstract::Human prostate specimens from 25 patients provided 15 normal, four benign prostatic hypertrophy (BPH), and seven adenocarcinoma samples which were studied using a polyclonal antibody against prostatic specific antigen (PSA) and protein A-gold complex. Our study showed the presence of gold particles in cytoplasmic vesi...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19870915)60:6<1288::aid-cncr2820

    authors: Sinha AA,Wilson MJ,Gleason DF

    更新日期:1987-09-15 00:00:00

  • Gastric pseudolymphoma. Its three subtypes and relation to lymphoma.

    abstract::Three separate histologic types of gastric pseudolymphoma (GPL) are described: (1) the common "inflammatory" type usually accompanied by ulceration and extensive fibrosis; (2) the entity known as "nodular lymphoid hyperplasia," which was associated with multiple intestinal lesions; and (3) the third reported case of a...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(19830201)51:3<476::aid-cncr28205

    authors: Brooks JJ,Enterline HT

    更新日期:1983-02-01 00:00:00

  • Essential thrombocythemia. Clinical characteristics and course of 61 cases.

    abstract::Sixty-one patients with essential thrombocythemia (ET) were followed from 1974 through 1987 at the Medizinische Poliklinik. Fifty-one patients (84%) presented with thromboembolic complications, and eight patients (13%) with hemorrhages. In seven patients (12%), a thrombocytosis was detected accidentally. Disturbances ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19880615)61:12<2487::aid-cncr282

    authors: Hehlmann R,Jahn M,Baumann B,Köpcke W

    更新日期:1988-06-15 00:00:00

  • Mutations of the p53 gene in male breast cancer.

    abstract:BACKGROUND:Cancer of the male breast (MBC) is rare, accounting for less than 1% of cancer in males and representing less than 1% of all breast cancers. Reports of abnormalities in the expression of the tumor suppressor gene p53 in MBC have been few. METHODS:To assess the expression and mutations of the p53 gene, 35 pa...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19950501)75:9<2233::aid-cncr2820

    authors: Anelli A,Anelli TF,Youngson B,Rosen PP,Borgen PI

    更新日期:1995-05-01 00:00:00

  • Sarcomatoid renal cell carcinoma: clinicopathologic. A study of 42 cases.

    abstract::Forty-two cases of sarcomatoid renal cell carcinoma were reviewed clinicopathologically. Twenty-four patients were men, and 18 women; average age was 56.2 years (range, 30-81 years). Eight, 9, 13, and 12 cases were Stages I, II, III, and IV, respectively. Three morphologic patterns of sarcomatoid components were ident...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19870201)59:3<516::aid-cncr28205

    authors: Ro JY,Ayala AG,Sella A,Samuels ML,Swanson DA

    更新日期:1987-02-01 00:00:00

  • High-dose melphalan-based autotransplants for multiple myeloma: the Arkansas experience since 1989 in 3077 patients.

    abstract:BACKGROUND:In this report, the authors describe their collective experience with melphalan-based autotransplants since the inception of their program at the University of Arkansas for Medical Sciences in 1989. METHODS:The authors evaluated the clinical outcomes of 3077 successive patients with multiple myeloma (MM) wh...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23327

    authors: Pineda-Roman M,Barlogie B,Anaissie E,Zangari M,Bolejack V,van Rhee F,Tricot G,Crowley J

    更新日期:2008-04-15 00:00:00

  • Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma.

    abstract:BACKGROUND:This study was designed to evaluate the significance of tumor angiogenesis and angiogenic factors such as hepatocyte growth factor (HGF) and c-Met in determining the prognoses of 93 patients with endometrial carcinoma. METHODS:By immunohistochemical staining, this retrospective study investigated tumor angi...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19980201)82:3<520::aid-cnc

    authors: Wagatsuma S,Konno R,Sato S,Yajima A

    更新日期:1998-02-01 00:00:00

  • Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000.

    abstract:BACKGROUND:Previous investigators have detected shifts to lower stages at diagnosis for renal cell carcinoma and prostate cancer. The authors investigated whether a similar pattern is seen for urothelial carcinomas of the bladder, ureter, and renal pelvis and sought to identify changes in cancer grade and survival tren...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.24147

    authors: David KA,Mallin K,Milowsky MI,Ritchey J,Carroll PR,Nanus DM

    更新日期:2009-04-01 00:00:00

  • Prognosis of the second breast cancer. The role of previous exposure to the first primary.

    abstract::With increasing evidence that cancer patients respond immunologically to their cancers, it seemed interesting to investigate whether or not the course of the second cancer differed from that of the first. If we assume that, in analogy to mammary cancer in the mouse, the cells of human breast cancers carry shared antig...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197503)35:3<596::aid-cncr2820350

    authors: Khafagy MM,Schottenfeld D,Robbins GF

    更新日期:1975-03-01 00:00:00

  • A possible association between aprotinin and improved survival after radical surgery for mesothelioma.

    abstract:BACKGROUND:Aprotinin has been used to decrease blood loss with complicated cardiac surgery but has not been investigated in extrapleural pneumonectomy, an operation that does not use cardiopulmonary bypass. In this prospective, randomized, placebo-controlled, double-blind trial, the authors investigated whether aprotin...

    journal_title:Cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/cncr.24108

    authors: Norman PH,Thall PF,Purugganan RV,Riedel BJ,Thakar DR,Rice DC,Huynh L,Qiao W,Wen S,Smythe WR

    更新日期:2009-02-15 00:00:00

  • The sequential changes in DNA synthesis, glucose utilization, protein synthesis, and peripheral benzodiazepine receptor density in C6 brain tumors after chemotherapy to predict the response of tumors to chemotherapy.

    abstract:BACKGROUND:Monitoring therapy in patients with brain tumors is very difficult and unreliable. It has been shown that there is no good correlation between tumor sensitivity measured in vitro and in situ tumor response to therapies. METHODS:Sequential changes in tumor size, number of DNA synthesizing cells (labelling in...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19960315)77:6<1167::aid-cn

    authors: Takeda N,Diksic M,Yamamoto YL

    更新日期:1996-03-15 00:00:00

  • A phase II trial of dexamethasone, vitamin D, and carboplatin in patients with hormone-refractory prostate cancer.

    abstract:BACKGROUND:A Phase II prospective trial was performed to study the efficacy of combination therapy with dexamethasone, calcitriol (1,25-dihydroxyvitamin D3), and carboplatin in patients with hormone-refractory prostate cancer (HRPC). Preclinical data from prostate cancer cell lines suggested a synergistic effect of the...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.21982

    authors: Flaig TW,Barqawi A,Miller G,Kane M,Zeng C,Crawford ED,Glodé LM

    更新日期:2006-07-15 00:00:00

  • Obesity, non-protein-bound estradiol levels, and distribution of estradiol in the sera of breast cancer patients.

    abstract::This study attempted to determine the relationship of nutritional status, menopausal status, presence of breast cancer, stage of disease, and tumor estrogen receptor levels to percent non-protein-bound estradiol (%NPBE) and percent distribution of estradiol on sex hormone-binding globulin (SHBG) and albumin in breast ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19860201)57:3<558::aid-cncr28205

    authors: Ota DM,Jones LA,Jackson GL,Jackson PM,Kemp K,Bauman D

    更新日期:1986-02-01 00:00:00

  • The effect of Medicaid expansion among adults from low-income communities on stage at diagnosis in those with screening-amenable cancers.

    abstract:BACKGROUND:Several states have opted to expand Medicaid under the Patient Protection and Affordable Care Act (ACA), which offers insurance coverage to low-income individuals up to 138% of the federal poverty level. This expansion of Medicaid to a medically vulnerable population potentially can reduce cancer outcome dis...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.32895

    authors: Kim U,Koroukian S,Statler A,Rose J

    更新日期:2020-09-15 00:00:00

  • Radiation-adriamycin interactions: preliminary clinical observations.

    abstract::This communication reports four patients treated with the anthracycline adriamycin and irradiation either concurrently or sequentially, who demonstrated apparent augumentation of radiation reactions. Two of these patients demonstrated the so-called "recall" phenomenon. ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197509)36:3<946::aid-cncr2820360

    authors: Cassady JR,Richter MP,Piro AJ,Jaffe N

    更新日期:1975-09-01 00:00:00

  • Present and future projects of the International Breast Cancer Study Group.

    abstract::The International Breast Cancer Study Group (formerly the Ludwig Group) has conducted nine clinical trials since 1978 (see the Appendix for participants and authors). Biologic hypotheses related to the combined use of chemotherapy and endocrine therapy in women with operable breast cancer were tested. Questions of tim...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19940801)74:3+<1139::aid-cncr282

    authors: Goldhirsch A,Gelber RD,Castiglione M,Price KN,Rudenstam CM,Lindtner J,Collins J,Senn HJ,Brunner KW,Galligioni E

    更新日期:1994-08-01 00:00:00

  • Comparison of Akt/mTOR signaling in primary breast tumors and matched distant metastases.

    abstract:BACKGROUND:The Akt/mammalian target of the rapamycin (mTOR) signaling pathway represents a promising target for cancer therapy. The phosphorylation status of Akt and of mTOR's phosphorylation target eukaryotic initiation factor 4E-binding protein 1 (4E-BP1) is often used to assess the activity of Akt and mTOR signaling...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23456

    authors: Akcakanat A,Sahin A,Shaye AN,Velasco MA,Meric-Bernstam F

    更新日期:2008-06-01 00:00:00

  • The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia.

    abstract:BACKGROUND:Clinical trials of monoclonal antibodies in combination with chemotherapy have reported previously unattained response rates in patients with B-cell chronic lymphocytic leukemia (B-CLL); however, the analysis of ZAP-70 protein and/or CD38 may explain better the discordant outcomes independent of treatment. ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.21535

    authors: Del Poeta G,Del Principe MI,Consalvo MA,Maurillo L,Buccisano F,Venditti A,Mazzone C,Bruno A,Gianní L,Capelli G,Lo Coco F,Cantonetti M,Gattei V,Amadori S

    更新日期:2005-12-15 00:00:00

  • Hyperfractionated cyclophosphamide with high-doses of arabinosylcytosine and methotrexate (HyperCHiDAM Verona 897).

    abstract:BACKGROUND:Patients who have aggressive, refractory or recurrent non-Hodgkin lymphomas (NHLs) that are refractory to first-line anthracycline-containing regimens (ACRs) have a dismal outcome. Achieving complete remission (CR) is essential for a favorable outcome. To improve the CR rate in these patients, the authors de...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.21150

    authors: Todeschini G,Tecchio C,Pasini F,Benedetti F,Cantini M,Crippa C,Draisci M,Pizzolo G

    更新日期:2005-08-01 00:00:00